Global AI in Vaccine Development Market Size To Grow At 39.45% CAGR From 2023 to 2030

AI in Vaccine Development Market Analysis (2023 - 2030)

As per our research report, the global AI in Vaccine Development market size is estimated to be growing at a CAGR of 39.45% from 2023 to 2030.

AI in vaccine development is witnessing an increase in recent years due to the rising incidence of infectious diseases. This has further induced researchers and biotechnologists to research and stout AI’s applications in healthcare, particularly in vaccine development. Moreover, it helps them to facilitate clinical trials, discover drug delivery mechanisms, search for target infectious regions, and manage drug distributions effectively.

The pandemic had a significant impact on the AI in vaccine development market. Due to the pandemic, there was an increasing need to develop vaccines that could curb the virus mutation and safeguard the health of people. This induced companies, universities, and organizations to introduce vaccine samples with AI that can help to eliminate the virus's impact on patients. These include Baidu’s Research Team collaboration with Oregon State University and the University of Rochester created an AI tool – LinearFold for vaccines. Further, Pfizer, a biopharmaceutical company utilized AI in vaccines for smart analytics and for tracking vaccine delivery.

Furthermore, AI algorithms were used to analyze the genetic structure of vaccines and predict mutations and vaccine treatment recommendations. Additionally, machine learning models are used by researchers to learn about the vaccine delivery process into the body and its impact on the cells. Moreover, AI helped health professionals to monitor vaccine safety during the delivery process such as temperature and quality checks, vaccine requirements in targeted areas, and others. This further helped to streamline the supply chain management by ensuring the effective and accurate allocation of vaccines to high-risk regions.

Furthermore, AI tools enabled health professionals to analyze diagnostic tests and monitor the spread of the virus, thus providing beforehand information regarding virus information. Additionally, AI-powered tools were used to study complex immune responses to SARS-CoV-2 infection and vaccination, integrating and collecting data from various sources it helped researchers gain valuable insights about the responsiveness of immune systems to viruses and vaccines.

Furthermore, some of the AI tools used to develop vaccines include machine learning algorithms, natural language processing, deep learning, virtual screening, epidemiological modeling, and others. Post-pandemic, there is an increasing trend in incorporating big data analytics for studying potential future virus mutations, which can help researchers in developing suitable vaccines. The restraints to this market include inaccuracy in data collection, validation, and sharing of vaccine data; and high initial infrastructure investment expenses.

KEY MARKET INSIGHTS:

• Based on market segmentation by application, vaccine clinical developments, and trials occupy the highest share of the market. The vaccine development stage is essential, as it testifies to the accuracy and delivery of vaccines in the human body, which is possible through the incorporation of AI. AI helps in monitoring and analyzing vaccine development such as monitoring the quality, detecting anomalies, reducing materials spoilage, and others. Vaccine manufacturing and QC is the fastest-growing segment during the forecast period as it helps health professionals to understand the manufacturing defects in vaccines using advanced AI sensors. This further helps firms to reduce the losses due to the supply chain and increase productivity.

• Based on market segmentation by end-user, pharma, and biopharma companies occupies the highest share of the market. These companies were among the top users of AI in analyzing the impact of the COVID-19 virus and developing vaccine strategies based on the data collected. Further, large pharmaceutical firms used AI to perform quality checks and monitor the vaccine delivery process in targeted virus-infected areas during the pandemic. Furthermore, Research centers are the fastest-growing segment during the forecast period. AI enables research centers to study drug prototypes, understand their mechanisms, forecast future virus mutations, and provide preventive measures for high-risk regions.

• Based on market segmentation by region, North America occupies the highest share of the market.  Due to well-established research labs, advanced AI technologies, and medical science innovations, there is an increase in demand for AI in vaccine development in the region. This includes the use of big data and analytics to track vaccine delivery in virus-affected areas and IoT integration that performs quality checks on vaccine packaging, resistance to outer temperature, and others. Furthermore, Asia-Pacific is the fastest-growing region during the outlook period. With government support in the form of investments, schemes, and collaboration with tech startups and companies, there is an increase in demand for AI in vaccine development in the region.

• Companies playing a leading role in the Global AI in Vaccine Development Market profiled in this report are – Benevolent AI, Pfizer, Evaxion Biotech, AstraZeneca, Eli Lill, Moderna, Novartis, Baidu, Exscientia, Roche, VantAI, Sanofi, Cyclica, PathAI, Atomwise, and BioSymetrics.

By Application:

• Vaccine Exploration/Preclinical

• Vaccine Clinical Developments and Trials

• Vaccine Manufacturing and QC

By End-User:

• Pharmaceutical & biotechnology companies

• Contract Research Organization

• Research Centers

By Region:

• North America

• Europe

• Asia Pacific

• Middle East

• South America

For More Info, Request Sample Copy Of This Report @  https://virtuemarketresearch.com/report/ai-vaccine-development-market/request-sample